Latest Articles
- Diagnostic certainty and the eosinophil
Eosinophilic esophagitis can mimic gastroesophageal reflux disease, especially early in its course.
- The health care ‘iron triangle’ and the Patient Protection and Affordable Care Act
There is no way to increase access, improve quality, and decrease costs all at the same time.
- Genetics and hepatitis C: It’s good to be ‘CC’
In hepatitis C, people born with the IL28B CC genotype can count themselves luckier than those born with CT or TT.
- Denosumab: A novel antiresorptive drug for osteoporosis
What denosumab is, how it works, how well it works, and practical prescribing tips.
- Syncope from a twiddled ICD
A patient playing (“twiddling”) with his or her implanted cardioverter-defibrillator can dislodge the lead.
- Retroperitoneal cyst hemorrhage in polycystic kidney disease
Polycystic kidney disease is relatively common, and fewer than half of cases are diagnosed. The cysts often bleed.
- Selecting antithrombotic therapy for patients with atrial fibrillation
When considering anticoagulant therapy for patients with atrial fibrillation, one must balance the reduction in risk of thromboembolism that this therapy offers against the risk of bleeding that it poses. The American Heart Association, American College of Cardiology, and Heart Rhythm Society updated their atrial fibrillation guidelines in 2014. This review outlines a rationale for clinical decision-making based on the new guidelines and summarizes the currently approved drugs.